Symbols / FEMY Stock $5.27 +0.38% Femasys Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
FEMY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Ms. Kathy Lee-Sepsick M.B.A.
Exch · Country NCM · United States
Market Cap 15.91M
Enterprise Value 316.39M
Income -11.88M
Sales 2.38M
FCF (ttm) —
Book/sh 0.10
Cash/sh 0.09
Employees 51
Insider 10d —
IPO Jun 18, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.91
PEG —
P/S 6.69
P/B 53.78
P/C —
EV/EBITDA -19.76
EV/Sales 133.11
Quick Ratio 1.76
Current Ratio 3.91
Debt/Eq 64.86
LT Debt/Eq —
EPS (ttm) -4.80
EPS next Y -5.80
EPS Growth —
Revenue Growth 24.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-08
Earnings (prior) 2026-05-08
ROA -68.65%
ROE -255.96%
ROIC —
Gross Margin 61.56%
Oper. Margin -9.94%
Profit Margin 0.00%
Shs Outstand 3.02M
Shs Float 49.93M
Insider Own 9.28%
Instit Own 10.13%
Short Float 5.77%
Short Ratio 1.76
Short Interest 166.32K
52W High 22.20
vs 52W High -76.26%
52W Low 5.09
vs 52W Low 3.54%
Beta —
Impl. Vol. —
Rel Volume 0.07
Avg Volume 55.51K
Volume 3.87K
Target (mean) $63.33
Tgt Median $30.00
Tgt Low $30.00
Tgt High $130.00
# Analysts —
Recom None
Prev Close $5.25
Price $5.27
Change 0.38%
About

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$63.33
Mean price target
2. Current target
$5.26
Latest analyst target
3. DCF / Fair value
$63.33
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$5.26
Low
$30.00
High
$130.00
Mean
$63.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-03 init Lake Street — → Buy $2
2025-11-20 init Laidlaw & Co. — → Buy $7
2025-08-11 main HC Wainwright & Co. Buy → Buy $8
2025-06-25 reit HC Wainwright & Co. Buy → Buy $12
2025-06-11 reit HC Wainwright & Co. Buy → Buy $12
2025-05-13 main Jones Trading Buy → Buy $6
2025-05-09 main HC Wainwright & Co. Buy → Buy $12
2025-03-28 reit HC Wainwright & Co. Buy → Buy $15
2025-03-19 main HC Wainwright & Co. Buy → Buy $15
2025-03-18 reit HC Wainwright & Co. Buy → Buy $12
2025-03-13 reit HC Wainwright & Co. Buy → Buy $12
2025-02-26 reit HC Wainwright & Co. Buy → Buy $12
2025-02-11 reit HC Wainwright & Co. Buy → Buy $12
2024-12-03 reit HC Wainwright & Co. Buy → Buy $12
2024-11-27 reit HC Wainwright & Co. Buy → Buy $12
2024-11-13 main Chardan Capital Buy → Buy $8
2024-11-12 reit HC Wainwright & Co. Buy → Buy $12
2024-10-31 reit HC Wainwright & Co. Buy → Buy $12
2024-09-12 reit HC Wainwright & Co. Buy → Buy $12
2024-08-14 main Chardan Capital Buy → Buy $10
News
RSS: Latest FEMY news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2.29
+40.77%
1.63
+51.97%
1.07
-11.13%
1.21
Operating Revenue
2.29
+40.77%
1.63
+51.97%
1.07
-11.13%
1.21
Cost Of Revenue
0.87
+60.10%
0.54
+43.37%
0.38
-14.00%
0.44
Reconciled Cost Of Revenue
0.36
-33.20%
0.54
+43.37%
0.38
+233.30%
0.11
Gross Profit
1.42
+31.06%
1.08
+56.70%
0.69
-9.47%
0.76
Operating Expense
19.01
+0.74%
18.87
+24.14%
15.20
+22.93%
12.36
Research And Development
7.58
-7.78%
8.22
+13.98%
7.21
+23.99%
5.81
Selling General And Administration
11.09
+7.08%
10.36
+37.93%
7.51
+25.35%
5.99
Selling And Marketing Expense
4.44
+10.26%
4.03
+519.90%
0.65
+16.33%
0.56
General And Administrative Expense
6.65
+5.06%
6.33
-7.76%
6.86
+26.28%
5.43
Other Gand A
6.65
+5.06%
6.33
-7.76%
6.86
+26.28%
5.43
Total Expenses
19.88
+2.41%
19.41
+24.61%
15.58
+21.66%
12.81
Operating Income
-17.59
+1.11%
-17.79
-22.59%
-14.51
-25.07%
-11.60
Total Operating Income As Reported
-17.59
+1.11%
-17.79
-22.59%
-14.51
-25.07%
-11.60
EBITDA
-15.89
+2.73%
-16.33
-24.01%
-13.17
-25.60%
-10.49
Normalized EBITDA
-17.12
-4.82%
-16.33
-24.01%
-13.17
-25.60%
-10.49
Reconciled Depreciation
0.85
-2.47%
0.87
-3.96%
0.91
+2.12%
0.89
EBIT
-16.74
+2.72%
-17.20
-22.21%
-14.08
-23.76%
-11.37
Total Unusual Items
1.23
—
—
—
Total Unusual Items Excluding Goodwill
1.23
—
—
—
Net Income
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Pretax Income
-18.63
+0.96%
-18.81
-32.05%
-14.24
-25.07%
-11.39
Net Non Operating Interest Income Expense
-1.79
-75.22%
-1.02
-484.45%
0.27
+23.72%
0.21
Interest Expense Non Operating
1.89
+17.93%
1.60
+869.57%
0.17
+1128.39%
0.01
Net Interest Income
-1.79
-75.22%
-1.02
-484.45%
0.27
+23.72%
0.21
Interest Expense
1.89
+17.93%
1.60
+869.57%
0.17
+1128.39%
0.01
Interest Income Non Operating
0.10
-82.53%
0.58
+35.11%
0.43
+88.91%
0.23
Interest Income
0.10
-82.53%
0.58
+35.11%
0.43
+88.91%
0.23
Other Income Expense
0.75
—
—
-0.00
Other Non Operating Income Expenses
-0.48
—
—
-0.00
Gain On Sale Of Security
1.23
—
—
—
Tax Provision
0.00
-86.49%
0.01
+121.35%
0.00
-31.14%
0.01
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Net Income From Continuing Operation Net Minority Interest
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Net Income From Continuing And Discontinued Operation
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Net Income Continuous Operations
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Normalized Income
-19.86
-5.55%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Net Income Common Stockholders
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Diluted EPS
-9.40
+44.71%
-17.00
+8.60%
-18.60
+3.12%
-19.20
Basic EPS
-9.40
+44.71%
-17.00
+8.60%
-18.60
+3.12%
-19.20
Basic Average Shares
1.98
+77.61%
1.11
+44.74%
0.77
+30.21%
0.59
Diluted Average Shares
1.98
+77.61%
1.11
+44.74%
0.77
+30.21%
0.59
Diluted NI Availto Com Stockholders
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Depreciation Amortization Depletion Income Statement
0.34
+15.04%
0.30
-38.50%
0.48
-13.85%
0.56
Depreciation And Amortization In Income Statement
0.34
+15.04%
0.30
-38.50%
0.48
-13.85%
0.56
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
20.72
+66.53%
12.45
-55.16%
27.76
+64.28%
16.90
Current Assets
16.46
+105.13%
8.02
-65.39%
23.18
+64.02%
14.13
Cash Cash Equivalents And Short Term Investments
9.27
+168.45%
3.45
-84.11%
21.72
+67.54%
12.96
Cash And Cash Equivalents
9.27
+168.45%
3.45
-84.11%
21.72
+67.54%
12.96
Cash Equivalents
—
3.45
—
—
Receivables
0.62
+26.26%
0.49
+393.77%
0.10
+27.67%
0.08
Accounts Receivable
0.62
+26.26%
0.49
+393.77%
0.10
+27.67%
0.08
Gross Accounts Receivable
0.63
+26.53%
0.50
+393.90%
0.10
+26.90%
0.08
Allowance For Doubtful Accounts Receivable
-0.01
-40.13%
-0.01
-400.00%
-0.00
+2.34%
-0.00
Inventory
5.74
+88.43%
3.05
+356.64%
0.67
+52.76%
0.44
Raw Materials
2.06
+57.43%
1.31
+255.73%
0.37
+50.49%
0.24
Work In Process
1.27
+28.89%
0.98
+661.77%
0.13
+28.41%
0.10
Finished Goods
2.41
+219.70%
0.75
+343.52%
0.17
+85.45%
0.09
Other Current Assets
0.83
-19.58%
1.04
+48.88%
0.70
+6.18%
0.66
Total Non Current Assets
4.27
-3.50%
4.42
-3.39%
4.58
+65.62%
2.76
Net PPE
3.19
-6.14%
3.40
-2.57%
3.49
+93.68%
1.80
Gross PPE
7.00
-2.05%
7.14
+1.50%
7.04
+40.18%
5.02
Accumulated Depreciation
-3.80
-1.66%
-3.74
-5.51%
-3.55
-10.20%
-3.22
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.56
+6.78%
3.34
+10.41%
3.02
-2.26%
3.09
Construction In Progress
0.90
+17.76%
0.76
+80.21%
0.42
+2.23%
0.41
Other Properties
1.30
-28.16%
1.81
-24.14%
2.38
+644.85%
0.32
Leases
1.24
+0.00%
1.24
+2.18%
1.21
+1.40%
1.20
Goodwill And Other Intangible Assets
0.13
+104.67%
0.07
0.00
-100.00%
0.00
Other Intangible Assets
—
0.07
—
0.00
Other Non Current Assets
0.94
-1.55%
0.95
-12.11%
1.09
+13.40%
0.96
Total Liabilities Net Minority Interest
14.85
+46.49%
10.14
+7.84%
9.40
+468.84%
1.65
Current Liabilities
3.64
-57.63%
8.58
+181.03%
3.05
+99.90%
1.53
Payables And Accrued Expenses
2.22
+15.93%
1.92
+28.00%
1.50
+69.96%
0.88
Payables
1.83
+28.97%
1.42
+23.40%
1.15
+113.89%
0.54
Accounts Payable
1.83
+28.97%
1.42
+24.72%
1.14
+122.77%
0.51
Current Accrued Expenses
0.39
-21.07%
0.50
+43.13%
0.35
+1.42%
0.34
Pensionand Other Post Retirement Benefit Plans Current
0.87
+33.83%
0.65
-39.89%
1.08
+1170.80%
0.09
Total Tax Payable
—
0.00
-100.00%
0.01
-54.77%
0.03
Current Debt And Capital Lease Obligation
0.49
-91.77%
5.92
+1356.88%
0.41
-21.06%
0.52
Current Debt
—
5.41
—
0.14
Other Current Borrowings
—
5.41
—
0.19
Current Capital Lease Obligation
0.49
-5.86%
0.52
+27.38%
0.41
+8.77%
0.37
Other Current Liabilities
0.05
-40.57%
0.09
+35.65%
0.07
+44.45%
0.05
Total Non Current Liabilities Net Minority Interest
11.22
+620.20%
1.56
-75.47%
6.35
+4969.53%
0.13
Long Term Debt And Capital Lease Obligation
4.21
+177.28%
1.52
-75.88%
6.29
+21920.17%
0.03
Long Term Debt
3.18
—
4.26
—
Long Term Capital Lease Obligation
1.03
-32.12%
1.52
-25.44%
2.04
+7023.10%
0.03
Other Non Current Liabilities
0.05
+32.21%
0.04
-27.89%
0.05
-43.17%
0.10
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
5.87
+154.70%
2.30
-87.44%
18.35
+20.40%
15.24
Common Stock Equity
5.87
+154.70%
2.30
-87.44%
18.35
+20.40%
15.24
Capital Stock
0.06
+154.42%
0.02
+7.80%
0.02
+81.66%
0.01
Common Stock
0.06
+154.42%
0.02
+7.80%
0.02
+81.66%
0.01
Preferred Stock
—
—
—
—
Share Issued
2.99
+154.42%
1.17
+7.80%
1.09
+81.65%
0.60
Ordinary Shares Number
2.98
+155.19%
1.17
+7.84%
1.08
+82.46%
0.59
Treasury Shares Number
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Additional Paid In Capital
146.45
+14.70%
127.68
+2.98%
123.99
+13.90%
108.86
Retained Earnings
-145.83
-14.64%
-127.20
-17.36%
-108.38
-15.13%
-94.13
Gains Losses Not Affecting Retained Earnings
—
—
—
—
Treasury Stock
0.06
+0.00%
0.06
+0.00%
0.06
+0.00%
0.06
Total Equity Gross Minority Interest
5.87
+154.70%
2.30
-87.44%
18.35
+20.40%
15.24
Total Capitalization
9.05
+292.64%
2.30
-89.81%
22.61
+48.34%
15.24
Working Capital
12.82
+2387.60%
-0.56
-102.78%
20.12
+59.67%
12.60
Invested Capital
9.05
+17.35%
7.71
-65.90%
22.61
+46.98%
15.38
Total Debt
4.70
-36.89%
7.44
+11.06%
6.70
+1132.43%
0.54
Net Debt
—
1.95
—
—
Capital Lease Obligations
1.52
-25.44%
2.04
-16.65%
2.44
+507.01%
0.40
Net Tangible Assets
5.73
+156.17%
2.24
-87.80%
18.35
+20.43%
15.24
Tangible Book Value
5.73
+156.17%
2.24
-87.80%
18.35
+20.43%
15.24
Current Notes Payable
—
—
0.00
-100.00%
0.14
Derivative Product Liabilities
6.96
0.00
—
—
Other Equity Interest
5.25
+182.05%
1.86
-33.26%
2.79
+390.72%
0.57
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-18.69
+3.87%
-19.44
-72.37%
-11.28
-5.11%
-10.73
Cash Flow From Continuing Operating Activities
-18.69
+3.87%
-19.44
-72.37%
-11.28
-5.11%
-10.73
Net Income From Continuing Operations
-18.63
+1.00%
-18.82
-32.07%
-14.25
-25.04%
-11.39
Depreciation Amortization Depletion
0.85
-2.47%
0.87
-3.96%
0.91
+2.12%
0.89
Depreciation
0.80
-5.59%
0.85
-5.84%
0.90
+4.31%
0.87
Amortization Cash Flow
0.05
+129.27%
0.02
+511.41%
0.00
-84.89%
0.02
Depreciation And Amortization
0.85
-2.47%
0.87
-3.96%
0.91
+2.12%
0.89
Amortization Of Intangibles
0.05
+129.27%
0.02
+511.41%
0.00
-84.89%
0.02
Other Non Cash Items
1.52
+27.87%
1.19
+1004.61%
0.11
—
Stock Based Compensation
0.79
+77.90%
0.44
-34.27%
0.68
+200.39%
0.22
Provisionand Write Offof Assets
—
0.01
0.00
-100.00%
0.00
Operating Gains Losses
-1.17
-173376.63%
0.00
-98.58%
0.05
+1980.44%
0.00
Gain Loss On Investment Securities
-1.23
—
—
—
Gain Loss On Sale Of PPE
0.06
+9167.75%
0.00
-98.58%
0.05
+1980.44%
0.00
Change In Working Capital
-2.06
+34.43%
-3.14
-355.56%
1.23
+367.83%
-0.46
Change In Receivables
-0.13
+67.08%
-0.39
-1716.88%
-0.02
-415.79%
0.01
Changes In Account Receivables
-0.13
+67.08%
-0.39
-1716.88%
-0.02
-415.79%
0.01
Change In Inventory
-2.69
-13.23%
-2.38
-932.66%
-0.23
+0.93%
-0.23
Change In Prepaid Assets
0.50
+457.13%
-0.14
-149.31%
0.28
-4.63%
0.30
Change In Payables And Accrued Expense
0.81
+277.88%
0.21
-86.73%
1.61
+2073.00%
-0.08
Change In Accrued Expense
0.47
+6929.82%
0.01
-99.32%
0.99
+771.49%
-0.15
Change In Payable
0.33
+61.38%
0.21
-66.91%
0.63
+861.23%
0.07
Change In Account Payable
0.33
+61.38%
0.21
-66.91%
0.63
+861.23%
0.07
Change In Other Current Assets
—
—
—
0.30
Change In Other Current Liabilities
-0.54
-22.10%
-0.44
-6.13%
-0.42
+6.48%
-0.45
Investing Cash Flow
-0.63
+25.68%
-0.85
-489.06%
-0.14
+64.68%
-0.41
Cash Flow From Continuing Investing Activities
-0.63
+25.68%
-0.85
-489.06%
-0.14
+64.68%
-0.41
Net PPE Purchase And Sale
-0.53
+31.07%
-0.76
-429.27%
-0.14
+64.68%
-0.41
Purchase Of PPE
-0.53
+31.07%
-0.76
-429.27%
-0.14
+64.68%
-0.41
Capital Expenditure
-0.63
+25.68%
-0.85
-489.06%
-0.14
+64.68%
-0.41
Net Investment Purchase And Sale
—
—
—
—
Sale Of Investment
—
—
—
—
Net Intangibles Purchase And Sale
-0.11
-22.12%
-0.09
0.00
—
Purchase Of Intangibles
-0.11
-22.12%
-0.09
0.00
—
Financing Cash Flow
25.14
+1139.74%
2.03
-89.95%
20.18
+3060.28%
-0.68
Cash Flow From Continuing Financing Activities
25.14
+1139.74%
2.03
-89.95%
20.18
+3060.28%
-0.68
Net Issuance Payments Of Debt
4.15
0.00
-100.00%
6.22
+1278.10%
-0.53
Issuance Of Debt
12.00
0.00
-100.00%
6.85
0.00
Repayment Of Debt
-7.85
0.00
+100.00%
-0.63
-18.60%
-0.53
Long Term Debt Issuance
12.00
0.00
-100.00%
6.85
0.00
Long Term Debt Payments
-7.85
0.00
+100.00%
-0.63
-18.60%
-0.53
Net Long Term Debt Issuance
4.15
0.00
-100.00%
6.22
+1278.10%
-0.53
Net Common Stock Issuance
19.52
+864.00%
2.03
-82.49%
11.56
+19309.70%
0.06
Proceeds From Stock Option Exercised
3.41
+5303.15%
0.06
-98.29%
3.69
+18477.06%
0.02
Net Other Financing Charges
-1.95
-3102.26%
-0.06
+95.34%
-1.30
-459.54%
-0.23
Changes In Cash
5.81
+131.84%
-18.26
-308.64%
8.75
+174.06%
-11.82
Beginning Cash Position
3.45
-84.11%
21.72
+67.54%
12.96
-47.70%
24.78
End Cash Position
9.27
+168.45%
3.45
-84.11%
21.72
+67.54%
12.96
Free Cash Flow
-19.32
+4.79%
-20.29
-77.62%
-11.42
-2.56%
-11.14
Interest Paid Supplemental Data
0.01
-92.24%
0.11
+1020.87%
0.01
-26.45%
0.01
Income Tax Paid Supplemental Data
0.01
+19.24%
0.01
+25.45%
0.00
-9.90%
0.01
Amortization Of Securities
—
—
—
—
Common Stock Issuance
19.52
+864.00%
2.03
-82.49%
11.56
+19309.70%
0.06
Issuance Of Capital Stock
19.52
+864.00%
2.03
-82.49%
11.56
+19309.70%
0.06
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category